Skip to main content
. 2018 Apr 15;2018(4):CD000249. doi: 10.1002/14651858.CD000249.pub2
Study Reason for exclusion
Andersch 1988 Cross‐over trial which did not report data from the first phase of the study.
Chamberlain 1991 Treatment group received ethamsylate.
Drosdal 1993 Participants included women with IUD in situ.
Harrison 1976 Treatment group received ethamsylate.
Kasonde 1975 Participants had intrauterine coil devices in situ.
Kouides 2009 Participants had a proven coagulopathy.
Moghtadaei 2012 Author was contacted for further information about their study, to judge whether it should be included/excluded. No reply was received.
Muse 2010 There was no control group.
Najam 2010 Compared women taking tranexamic acid to those taking a combination of tranexamic acid and mefenamic acid.
NCT01190150 Dose‐finding RCT of tranexamic acid in girls aged 12 to 16 years.
NCT01428713 Data not provided for the end of the first phase of the cross‐over study.
NiIsson 1965 Treatment group received ethamsylate.
Nilsson 1967 Cross‐over trial which did not report data from the first phase of the study.
Petersen 1983 Treatment was given for only 1 month. Criterion specified in our protocol was that we would include only studies using at least 2 months of treatment.
Tabatabaei 2013 Author was contacted for further information about their study, to judge whether it should be included/excluded. No reply was received.
Vermylen 1968 Cross‐over trial which did not report data from the first phase of the study.
Westrom 1970 Participants had intrauterine coil devices in situ.
Ylikorkala 1983 Participants had intrauterine coil devices in situ.